Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/21/20
End: 05/20/25
Due: 05/20/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. | NCT04358237 | Antonio Calles Blanco | user2@example.com | None | 2020-09-21 | 2025-05-20 | 2026-05-20 | - | - | 2025-07-14 |